Literature DB >> 1656158

Beta-amyloid precursor protein gene is differentially expressed in axotomized sensory and motor systems.

J N Scott1, I M Parhad, A W Clark.   

Abstract

The beta-amyloid precursor protein (APP) is involved in the degenerative and regenerative neural changes associated with aging and Alzheimer's disease. We studied the regulation of APP gene expression in a paradigm of degeneration and regeneration, the axotomized rat sciatic system. The sciatic nerves of rats were crushed and at intervals between 4 and 60 days, the affected dorsal root ganglia and spinal cord segments were processed for Northern analysis and in situ hybridization to evaluate various APP mRNA species. After nerve crush, dorsal root ganglia APP mRNA levels are increased for both APP695 (695 amino acids) and APPKPI (Kunitz protease inhibitor). Following reinnervation, APP695 returns to baseline but APPKPI remains elevated. In spinal cord there is a decrease of APP695, which returns to baseline following reinnervation. If regeneration is prevented, the initial phase of post-axotomy response for all APP forms persists for at least 60 days in both dorsal root ganglia and spinal cord. In situ hybridization confirms that the changes are referable to neurons. These findings indicate that neuron-target interactions are important in APP gene regulation; that the APP695 and APPKPI transcripts are differentially regulated following neuronal injury; and that different neuronal populations regulate APP expression in a cell-type specific manner.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656158     DOI: 10.1016/0169-328x(91)90090-k

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  14 in total

1.  The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter.

Authors:  P Pollwein; C L Masters; K Beyreuther
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

Review 2.  Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.

Authors:  J Szczygielski; A Mautes; W I Steudel; P Falkai; T A Bayer; O Wirths
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

3.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease.

Authors:  G W Roberts; S M Gentleman; A Lynch; L Murray; M Landon; D I Graham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

Review 4.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

5.  Bundles of amyloid precursor protein-immunoreactive axons in human cerebrovascular white matter lesions.

Authors:  T Suenaga; K Ohnishi; M Nishimura; S Nakamura; I Akiguchi; J Kimura
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex.

Authors:  L J Martin; C A Pardo; L C Cork; D L Price
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

7.  Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein.

Authors:  T Uetsuki; K Takemoto; I Nishimura; M Okamoto; M Niinobe; T Momoi; M Miura; K Yoshikawa
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

8.  Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path.

Authors:  J D Buxbaum; G Thinakaran; V Koliatsos; J O'Callahan; H H Slunt; D L Price; S S Sisodia
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  UV irradiation accelerates amyloid precursor protein (APP) processing and disrupts APP axonal transport.

Authors:  Angels Almenar-Queralt; Tomas L Falzone; Zhouxin Shen; Concepcion Lillo; Rhiannon L Killian; Angela S Arreola; Emily D Niederst; Kheng S Ng; Sonia N Kim; Steven P Briggs; David S Williams; Lawrence S B Goldstein
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

10.  Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.